Emergence of a small colony variant of vancomycin-intermediate Staphylococcus aureus in a patient with septic arthritis during long-term treatment with daptomycin

Journal of Antimicrobial Chemotherapy

Volumn 71, Issue 7, 2016, Pages 1807-1814

  Lin, Yu Tzu ^a   Tsai, Jui Chang ^a,b   Yamamoto, Tatsuo ^c   Chen, Hsiao Jan ^a   Hung, Wei Chun ^d   Hsueh, Po Ren ^b   Teng, Lee Jene ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c International Medical Education and Research Center   (Japan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CLS2 PROTEIN; DAPTOMYCIN; ENDOPEPTIDASE CLPX; FABF PROTEIN; FATTY ACID SYNTHASE; LINEZOLID; MPRF GENE PROTEIN; OXACILLIN; UNCLASSIFIED DRUG; VANCOMYCIN; ANTIINFECTIVE AGENT;

AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL ARTHRITIS; BACTERIAL CHROMOSOME; BACTERIAL GROWTH; BACTERIUM COLONY; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CASE REPORT; CLONE; CONTROLLED STUDY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FATTY ACID ANALYSIS; FOLLOW UP; GENE CASSETTE; GENE MUTATION; GENETIC DIFFERENCE; GENOTYPE; HUMAN; INFUSION; LIPID COMPOSITION; LONG TERM CARE; MALE; NONHUMAN; STAPHYLOCOCCUS INFECTION; TRANSMISSION ELECTRON MICROSCOPY; VANCOMYCIN INTERMEDIATE STAPHYLOCOCCUS AUREUS; ARTHRITIS, INFECTIOUS; DRUG EFFECTS; ELECTRON MICROSCOPY; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTILOCUS SEQUENCE TYPING; PHENOTYPE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TIME; ULTRASTRUCTURE;

AGED; ANTI-BACTERIAL AGENTS; ARTHRITIS, INFECTIOUS; DAPTOMYCIN; DRUG RESISTANCE, BACTERIAL; GENOTYPE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON; MULTILOCUS SEQUENCE TYPING; PHENOTYPE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TIME; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 84978982792     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkw060     Document Type: Article

References (42)

1. Chen YS. Guidelines for the treatment of methicillin-resistant Staphylococcus aureus infections in Taiwan. J Microbiol Immunol Infect 2013; 46: 147-50
2. Fridkin SK, Hageman J, McDougal LK et al. Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001. Clin Infect Dis 2003; 36: 429-39
3. Howden BP, Ward PB, Charles PG et al. Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility. Clin Infect Dis 2004; 38: 521-8
4. Pillai SK, Wennersten C, Venkataraman L et al. Development of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus. Clin Infect Dis 2009; 49: 1169-74
5. Jung D, Powers JP, Straus SK et al. Lipid-specific binding of the calciumdependent antibiotic daptomycin leads to changes in lipid polymorphism of model membranes. Chem Phys Lipids 2008; 154: 120-8
6. Cotroneo N, Harris R, Perlmutter N et al. Daptomycin exerts bactericidal activity without lysis of Staphylococcus aureus. Antimicrob Agents Chemother 2008; 52: 2223-5
7. Peleg AY, Miyakis S, Ward DVet al. Whole genome characterization of the mechanisms of daptomycin resistance in clinical and laboratory derived isolates of Staphylococcus aureus. PLoS One 2012; 7: e28316
8. Camargo IL, Neoh HM, Cui L et al. Serial daptomycin selection generates daptomycin-nonsusceptible Staphylococcus aureus strains with a heterogeneous vancomycin-intermediate phenotype. Antimicrob Agents Chemother 2008; 52: 4289-99
9. Friedman L, Alder JD, Silverman JA. Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus. Antimicrob Agents Chemother 2006; 50: 2137-45
10. Yang SJ, Kreiswirth BN, Sakoulas G et al. Enhanced expression of dltABCD is associated with the development of daptomycin nonsusceptibility in a clinical endocarditis isolate of Staphylococcus aureus. J Infect Dis 2009; 200: 1916-20
11. Mishra NN, Liu GY, Yeaman MR et al. Carotenoid-related alteration of cell membrane fluidity impacts Staphylococcus aureus susceptibility to host defense peptides. Antimicrob Agents Chemother 2011; 55: 526-31
12. Cui L, Tominaga E, Neoh HMet al. Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus. Antimicrob Agents Chemother 2006; 50: 1079-82
13. Proctor RA, van Langevelde P, Kristjansson M et al. Persistent and relapsing infections associated with small-colony variants of Staphylococcus aureus. Clin Infect Dis 1995; 20: 95-102
14. Bayston R, Ashraf W, Smith T. Triclosan resistance in methicillinresistant Staphylococcus aureus expressed as small colony variants: a novel mode of evasion of susceptibility to antiseptics. J Antimicrob Chemother 2007; 59: 848-53
15. Abu-Qatouseh LF, Chinni SV, Seggewiss J et al. Identification of differentially expressed small non-protein-coding RNAs in Staphylococcus aureus displaying both the normal and the small-colony variant phenotype. J Mol Med (Berl) 2010; 88: 565-75
16. Proctor RA, von EiffC, Kahl BC et al. Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat Rev Microbiol 2006; 4: 295-305
17. Sendi P, Proctor RA. Staphylococcus aureus as an intracellular pathogen: the role of small colony variants. Trends Microbiol 2009; 17: 54-8
18. Gilligan PH, Gage PA, Welch DF et al. Prevalence of thymidinedependent Staphylococcus aureus in patients with cystic fibrosis. J Clin Microbiol 1987; 25: 1258-61
19. Murray BE, Singh KV, Heath JD et al. Comparison of genomic DNAs of different enterococcal isolates using restriction endonucleases with infrequent recognition sites. J Clin Microbiol 1990; 28: 2059-63
20. Chongtrakool P, Ito T, Ma XX et al. Staphylococcal cassette chromosome mec (SCCmec) typing of methicillin-resistant Staphylococcus aureus strains isolated in 11 Asian countries: a proposal for a new nomenclature for SCCmec elements. Antimicrob Agents Chemother 2006; 50: 1001-12
21. Koreen L, Ramaswamy SV, Graviss EA et al. spa typing method for discriminating among Staphylococcus aureus isolates: implications for use of a single marker to detect genetic micro-and macrovariation. J Clin Microbiol 2004; 42: 792-9
22. Harmsen D, Claus H, Witte W et al. Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J Clin Microbiol 2003; 41: 5442-8
23. Enright MC, Day NP, Davies CE et al. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol 2000; 38: 1008-15
24. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-third Informational Supplement M100-S23. CLSI, Wayne, PA, USA, 2013
25. Zerbino DR, Birney E. Velvet: algorithms for de novo short read assembly using de Bruijn graphs. Genome Res 2008; 18: 821-9
26. Yamamoto T, Takano T, Fusegawa T et al. Electron microscopic structures, serum resistance, and plasmid restructuring of New Delhi metallob-lactamase-1 (NDM-1)-producing ST42 Klebsiella pneumoniae emerging in Japan. J Infect Chemother 2013; 19: 118-27
27. Hung WC, Chen HJ, Tsai JC et al. Gemella parahaemolysans sp. nov. and Gemella taiwanensis sp. nov., isolated fromhuman clinical specimens. Int J Syst Evol Microbiol 2014; 64: 2060-5
28. Kahl BC, Belling G, Reichelt R et al. Thymidine-dependent small-colony variants of Staphylococcus aureus exhibit gross morphological and ultrastructural changes consistent with impaired cell separation. J Clin Microbiol 2003; 41: 410-3
29. Jenke-Kodama H, Sandmann A, Muller R et al. Evolutionary implications of bacterial polyketide synthases. Mol Biol Evol 2005; 22: 2027-39
30. Kaplan ML, Dye W. Growth requirements of some small-colony-forming variants of Staphylococcus aureus. J Clin Microbiol 1976; 4: 343-8
31. Brinster S, Lamberet G, Staels B et al. Type II fatty acid synthesis is not a suitable antibiotic target for Gram-positive pathogens. Nature 2009; 458: 83-6
32. Inglis B, Matthews PR, Stewart PR. Induced deletions within a cluster of resistance genes in the mec region of the chromosome of Staphylococcus aureus. J Gen Microbiol 1990; 136: 2231-9
33. Annear DI, Grubb WB. Methicillin-sensitive variants in ageing broth cultures of methicillin-resistant Staphylococcus aureus. Pathology 1976; 8: 69-72
34. Sieradzki K, Leski T, Dick J et al. Evolution of a vancomycin-intermediate Staphylococcus aureus strain in vivo: multiple changes in the antibiotic resistance phenotypes of a single lineage of methicillin-resistant S. aureus under the impact of antibiotics administered for chemotherapy. J Clin Microbiol 2003; 41: 1687-93
35. Adhikari RP, Scales GC, Kobayashi K et al. Vancomycin-induced deletion of the methicillin resistance gene mecA in Staphylococcus aureus. J Antimicrob Chemother 2004; 54: 360-3
36. Higgins PG, Rosato AE, Seifert H et al. Differential expression of ccrA in methicillin-resistant Staphylococcus aureus strains carrying staphylococcal cassette chromosome mec type II and IVa elements. Antimicrob Agents Chemother 2009; 53: 4556-8
37. Reipert A, Ehlert K, Kast Tet al. Morphological and genetic differences in two isogenic Staphylococcus aureus strains with decreased susceptibilities to vancomycin. Antimicrob Agents Chemother 2003; 47: 568-76
38. Yang SJ, Xiong YQ, Boyle-Vavra S et al. Daptomycin-oxacillin combinations in treatment of experimental endocarditis caused by daptomycinnonsusceptible strains of methicillin-resistant Staphylococcus aureus with evolving oxacillin susceptibility (the 'seesaw effect'). Antimicrob Agents Chemother 2010; 54: 3161-9
39. Ernst CM, Staubitz P, Mishra NN et al. The bacterial defensin resistance protein MprF consists of separable domains for lipid lysinylation and antimicrobial peptide repulsion. PLoS Pathog 2009; 5: e1000660
40. Mishra NN, Yang SJ, Sawa A et al. Analysis of cell membrane characteristics of in vitro-selected daptomycin-resistant strains of methicillinresistant Staphylococcus aureus. Antimicrob Agents Chemother 2009; 53: 2312-8
41. Tropp BE. Cardiolipin synthase from Escherichia coli. Biochim Biophys Acta 1997; 1348: 192-200
42. Zhang YM, Rock CO. Membrane lipid homeostasis in bacteria. Nat Rev Microbiol 2008; 6: 222-33